Abstracts
303
URINARY VCAM 1 AS A DISEASE ACTIVITY INDICATOR
IN LUPUS NEPHRITIS
S Padiyar*, 1J Mathew, 2TS Vijayakumar. 1Christian Medical College, RHEUMATOLOGY,
Vellore- Tamilnadu, India; 2Christian Medical College, NEPHROLOGY, Vellore- Tamilnadu,
India
1
10.1136/lupus-2017-000215.303
Abstract 303 Figure 1
LUPUS 2017;4(Suppl 1):A1–A227
Abstract 303 Figure 2
Background and aims Currently we do not have a biomarker
that can closely reflect the renal disease activity. So the aim of
this study is to study the utility of urinary VCAM 1(Vascular
cell adhesion molecule 1) in lupus nephritis.
Methods It was a diagnostic case control study. The patients
presenting to Rheumatology outpatient department were
recruited. Patients were divided into 2 groups, SLE without
active nephritis and SLE with active nephritis based on the
renal SLEDAI. Urinary VCAM1 was tested in all patients
using an early morning spot urine sample using ELISA. Renal
biopsy was done in patients with active nephritis. VCAM1
levels were compared with the renal SLEDAI, renal biopsy disease activity (ISNRPS) and standard of care markers. The
results were analysd using SPSS software version 16.The validity and predictive value statistics was presented with 95 percent confidence interval.
Results Urinary VCAM 1 levels had significant correlation
(p=0.01) with disease activity based on renal SLEDAI. However, the correlation between the biopsy findings and VCAM
levels was not statistically significant. Class 4 and 5 lupus
nephritis had higher VCAM level than the lower classes. A
positive correlation (r=0.38) was found between VCAM 1
and double stranded DNA. There was a negative correlation
between C3 value and VCAM (r= 0.19). The sensitivity and
specificity of urinary VCAM 1 is 65.22% and 75% respectively. The cut off value of VCAM is 23.8 pg/mg of
creatinine.
Conclusions Urinary VCAM 1 may not independently, but
combined with other markers may be a promising biomarker
for disease activity in lupus nephritis.
A137
Lupus Sci Med: first published as 10.1136/lupus-2017-000215.303 on 24 March 2017. Downloaded from http://lupus.bmj.com/ on May 21, 2020 by guest. Protected by copyright.
in vitro with IL-3 for 6 or 24 hours. WB RNASeq analysis
was also undertaken in n=31 SLE donors from the Monash
Lupus Clinic and n=28 HDs.
Results Serum IL-3 levels correlated with serum IFNa
(r=0.612, 95% CI 0.455–0.733, p<0.001). IL-3 stimulation in
vitro altered 794 genes ( 1logFC 1, FDR<0.05). Thirtyfive of these genes overlapped with differentially expressed
genes between SLE and HD. These 35 genes were expressed
in 28/31 SLE donors, revealing the presence of an ‘IL-3 gene
signature’. There was strong correlation between the IL-3 signature and an IFN signature determined by heirarchical clustering of the five hundred most variable genes in SLE donors
(r=0.939, 95% CI 0.898–0.964, p<0.0001).
Conclusions We have previously reported a novel anti-IL-3Ra
mAb (CSL362/JNJ-473), which depletes pDCs and reduces
IFNa production, as well as neutralising IL-3 signalling (Oon
S, JCI Insight, 2016). An association between IL-3 and IFNa
was found in this study, raising the possibility that CSL362
may be especially useful for lupus patients with a dual IL-3/
IFN gene signature.
Abstracts
305
ASSOCIATION OF C4A AND C4B GENOMIC COPY
NUMBER VARIATIONS IN ADULT AND PAEDIATRIC
SYSTEMIC LUPUS ERYTHEMATOSUS
P Das*, RW Minz1,1B Saikia, 2A Sharma, 3S Singh. 1Postgraduate Institute of Medical
Education and Research – Chandigarh, Immunopathology, Chandigarh, India;
2
Postgraduate Institute of Medical Education and Research – Chandigarh, Internal
Medicine, Chandigarh, India; 3Postgraduate Institute of Medical Education and Research –
Chandigarh, Advanced Paediatric Centre, Chandigarh, India
1
10.1136/lupus-2017-000215.305
Abstract 303 Figure 3
304
TNF-A PROMOTER POLYMORPHISMS (G-238A AND G308A) ARE ASSOCIATED WITH SUSCEPTIBILITY TO
SYSTEMIC LUPUS ERYTHEMATOSUS: A STUDY IN P.
FALCIPARUM ENDEMIC AREA
AK Panda*,1H MAHATO, 2R Tripathy, 3BK Das. 1Central University of Jharkhand, Centre
for Life Sciences, Ranchi, India; 2SCB Medical College, Department of Biochemistry, cuttack,
India; 3SCB Medical College, Department of Medicine, cuttack, India
1
10.1136/lupus-2017-000215.304
Background and aims Tumour necrosis factor-a (TNF-a) is a
proinflammatory cytokine associated with P. falciparum malaria
and autoimmune disorders. Elevated plasma TNF-a has been
linked to P. falciparum malarial severity and mortality. Higher
levels of TNF-a has also been reported in systemic lupus
erythematosus (SLE). Two functional common polymorphisms
(G-238A and G-308A) at promoter region of TNF-a gene
have been linked to SLE susceptibility in different population.
In the present report, we conducted a case control study to
investigate association of TNF-a (G-238A and G-308A) polymorphisms with susceptibility/resistance to SLE development in
a P. falciparum malaria endemic cohort.
Methods A total of 204 female SLE patients and 224 age and
sex matched healthy controls were enrolled in the study.
TNF-a polymorphisms (G-238A and G-308A) were typed by
polymerase chain reaction and restriction length polymorphism
(PCR-RFLP). Plasma level of TNF-a was quantified by enzyme
linked immunosorbent assay.
A138
Background and aims C4 complement gene has been observed
to be a susceptibility gene for SLE. Lower C4 gene (C4A and
C4B) copy number (CN) is a risk factor for SLE, where as
higher C4 CN is a protective factor. We investigated the association of C4 gene copy number variation in a north Indian
cohort of SLE patients
Methods We recruited 112 aSLE and 52 pSLE patients with
115 healthy adult (CA) and 60 healthy paediatric (CP) controls and compared for C4A and C4B CN by RT-PCR, serum
C3, C4 by nephelometry and ANA autoantibodies by line blot
assay
Results C4A low copy number was higher in pSLE (OR=1.82,
p=0.67) and aSLE (OR=1.51, p=0.41) as compared to their
respective controls, pSLE had higher C4A low copy number
than the aSLE (OR=1.33, p=0.58), though they were not
statistically significant. C4A and C4B CN negatively correlated
with several ANA autoantibodies. The total C4 (C4A +C4B)
CN negatively correlated with Ro52 (r= 0.29, p=0.03),
dsDNA (r= 0.32, p=0.02), SSB (r= 0.33, p=0.01), nucleosome (r= 0.28, p=0.04) and histone (r= 0.34, p=0.01) in
pSLE and with nucleosome (r= 0.20, p=0.03) in aSLE. The
total C4 CN positively correlated with serum C4 level
(r=0.26, p=0.007) in both groups of patients
Conclusions We demonstrate that low copy numbers of complement genes correlate with the propensity for increased antibody secretion in both aSLE and pSLE. Thus, more
productions of autoantibodies cause large number of immune
complex formation with defective clearance process, due to
low serum C4 level and low gene copy number
LUPUS 2017;4(Suppl 1):A1–A227
Lupus Sci Med: first published as 10.1136/lupus-2017-000215.303 on 24 March 2017. Downloaded from http://lupus.bmj.com/ on May 21, 2020 by guest. Protected by copyright.
Results The prevalence of heterozygous mutants and minor
alleles of TNF-a (G-238A and G-308A) polymorphisms were
significantly higher in SLE patients compared to healthy controls. Furthermore, heterozygous (GA) and minor allele (A) of
TNF-a (G-238A) polymorphism were associated with susceptibility to lupus nephritis. SLE patients displayed higher levels
of plasma TNF-a compared to healthy controls. TNF-a (G238A and G-308A) variants were associated with higher
plasma TNF-a in both SLE patients and healthy control.
Conclusions The results of the present study demonstrate that
TNF-a (G-238A and G-308A) variants are associated with
higher plasma TNF-a level and increased susceptibility to
development of SLE in malarial endemic areas.